We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase II Trial of SNG001 in Coronavirus Patients Set To Start

News   Mar 18, 2020 | Original story from Synairgen

 
Phase II Trial of SNG001 in Coronavirus Patients Set To Start

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Early Immunological Studies Show Universally Effective Antibodies Against SARS-CoV-2 in Recovered Humans

News

The first round of results from an immunological study of 149 people who have recovered from COVID-19 show that although the amount of antibodies they generated varies widely, most individuals had generated at least some that were intrinsically capable of neutralizing the SARS-CoV-2 virus.

READ MORE

Beware of False Negatives in Diagnostic Testing of COVID-19

News

Researchers at Johns Hopkins have found that the chance of a false negative result — when a virus is not detected in a person who actually is, or recently has been, infected — is greater than 1 in 5 and, at times, far higher.

READ MORE

Rat Study Suggests "Good Bacteria" Could Relieve Autism-like Symptoms in Pregnancy

News

Giving beneficial bacteria to stressed mothers during the equivalent of the third trimester of pregnancy prevents an autism-like disorder in their offspring, according to a new animal study by University of Colorado Boulder researchers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE